company background image
MDT logo

Medtronic NYSE:MDT Rapport sur les actions

Dernier prix

US$87.59

Capitalisation boursière

US$112.3b

7D

-0.8%

1Y

16.5%

Mise à jour

18 Nov, 2024

Données

Finances de l'entreprise +

Medtronic plc

NYSE:MDT Rapport sur les actions

Capitalisation boursière : US$112.3b

MDT Aperçu des actions

Medtronic plc développe, fabrique et vend des thérapies médicales basées sur des dispositifs aux systèmes de santé, aux médecins, aux cliniciens et aux patients du monde entier. Plus de détails

MDT analyse fondamentale
Score flocon de neige
Évaluation5/6
Croissance future1/6
Performances passées3/6
Santé financière3/6
Dividendes4/6

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

Medtronic plc Concurrents

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour Medtronic
Historique des cours de bourse
Prix actuel de l'actionUS$87.59
Plus haut sur 52 semainesUS$92.68
Plus bas sur 52 semainesUS$74.66
Bêta0.85
1Variation sur 1 mois-5.04%
Variation sur 3 mois2.59%
Variation sur 1 an16.54%
3Variation sur 3 ans-25.07%
Variation sur 5 ans-21.64%
Évolution depuis l'introduction en bourse60,096.42%

Nouvelles et mises à jour récentes

Medtronic Q3 Earnings: A Solid Performance, But Bottom Line Still Needs Fixing

Nov 19

Medtronic (NYSE:MDT) Hasn't Managed To Accelerate Its Returns

Nov 08
Medtronic (NYSE:MDT) Hasn't Managed To Accelerate Its Returns

Medtronic: Undervalued But Trapped In Slow Growth (Rating Downgrade)

Oct 31

Recent updates

Medtronic Q3 Earnings: A Solid Performance, But Bottom Line Still Needs Fixing

Nov 19

Medtronic (NYSE:MDT) Hasn't Managed To Accelerate Its Returns

Nov 08
Medtronic (NYSE:MDT) Hasn't Managed To Accelerate Its Returns

Medtronic: Undervalued But Trapped In Slow Growth (Rating Downgrade)

Oct 31

Is It Time To Consider Buying Medtronic plc (NYSE:MDT)?

Oct 13
Is It Time To Consider Buying Medtronic plc (NYSE:MDT)?

Medtronic: Undervalued Dividend Aristocrat With High Margins

Oct 10

An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 33% Undervalued

Sep 30
An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 33% Undervalued

Medtronic (NYSE:MDT) Boosts FY 2025 Guidance Amid Strong Q1 Earnings and Strategic Share Buybacks

Sep 16
Medtronic (NYSE:MDT) Boosts FY 2025 Guidance Amid Strong Q1 Earnings and Strategic Share Buybacks

Medtronic: An Undervalued Stock With Durable Competitive Advantages

Sep 16

Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Sep 05
Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Medtronic: Is The Company Back?

Aug 26

Medtronic: Still A Buy Before Earnings

Aug 17

Returns At Medtronic (NYSE:MDT) Appear To Be Weighed Down

Aug 08
Returns At Medtronic (NYSE:MDT) Appear To Be Weighed Down

Medtronic: An Out Of Favor Healthcare Stock With A Pulse On Profit Potential

Jul 16

At US$77.06, Is Medtronic plc (NYSE:MDT) Worth Looking At Closely?

Jul 11
At US$77.06, Is Medtronic plc (NYSE:MDT) Worth Looking At Closely?

Medtronic (NYSE:MDT) Is Paying Out A Larger Dividend Than Last Year

Jun 27
Medtronic (NYSE:MDT) Is Paying Out A Larger Dividend Than Last Year

Medtronic: Why I Disagree With The Crowd

Jun 14

Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's

Jun 10
Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's

Medtronic: Net Income Could Fall $3.38B, The Stock Would Still Be Undervalued

May 27

Medtronic (NYSE:MDT) Has Announced That It Will Be Increasing Its Dividend To $0.70

May 26
Medtronic (NYSE:MDT) Has Announced That It Will Be Increasing Its Dividend To $0.70

These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well

May 22
These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well

Medtronic Stock Looks Promising Before Fiscal Q4 2024 Release

May 13

Is Medtronic plc (NYSE:MDT) Trading At A 20% Discount?

May 01
Is Medtronic plc (NYSE:MDT) Trading At A 20% Discount?

35% Undervalued? Medtronic's Future Looks Very Bright

Apr 12

Medtronic: Buy This Dividend Aristocrat Diamond In The Rough Now

Mar 27

Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth

Mar 11

Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69

Mar 11
Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69

Medtronic: Its Recent Beat Proves That It Continues To Be A Rock

Feb 25

Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts

Feb 22
Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts

Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility

Feb 16

A Look At The Fair Value Of Medtronic plc (NYSE:MDT)

Jan 31
A Look At The Fair Value Of Medtronic plc (NYSE:MDT)

Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?

Jan 16
Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?

Medtronic Stock's Rally Is Set To Continue

Jan 11

Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings

Dec 29
Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings

Medtronic's (NYSE:MDT) Dividend Will Be $0.69

Dec 12
Medtronic's (NYSE:MDT) Dividend Will Be $0.69

Medtronic: The GLP-1 Drug Headwinds Are Overblown

Dec 10

3.5% Yield And Over 15% Annual Return Potential - I Really Like Medtronic

Nov 28

Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes

Nov 19
Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes

Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings

Nov 17

Medtronic Faces Potential Decline Despite Financial Strength

Oct 29

An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued

Oct 19
An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued

Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Oct 04
Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Medtronic: Improved Guidance, Historically Cheap P/E, Yield Reaches 3.5%

Sep 27

Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Sep 18
Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Medtronic: The Tide Is Turning

Aug 24

Rendement pour les actionnaires

MDTUS Medical EquipmentUS Marché
7D-0.8%-0.7%-2.1%
1Y16.5%22.5%29.7%

Rendement vs Industrie: MDT a sous-performé le secteur US Medical Equipment qui a rapporté 22.5 % au cours de l'année écoulée.

Rendement vs marché: MDT a sous-performé le marché US qui a rapporté 29.7 % au cours de l'année écoulée.

Volatilité des prix

Is MDT's price volatile compared to industry and market?
MDT volatility
MDT Average Weekly Movement2.3%
Medical Equipment Industry Average Movement8.0%
Market Average Movement6.2%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market3.1%

Cours de l'action stable: MDT n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.

Volatilité au fil du temps: La volatilité hebdomadaire de MDT ( 2% ) est restée stable au cours de l'année écoulée.

À propos de l'entreprise

FondéeSalariésPDGSite web
194995,000Geoff Marthawww.medtronic.com

Medtronic plc développe, fabrique et vend des thérapies médicales basées sur des dispositifs aux systèmes de santé, aux médecins, aux cliniciens et aux patients du monde entier. Le segment Cardiovascular Portfolio propose des stimulateurs cardiaques implantables, des défibrillateurs cardioverteurs et des dispositifs de thérapie de resynchronisation cardiaque, des produits d'ablation cardiaque, des systèmes de moniteurs cardiaques insérables, des produits TYRX, ainsi que des logiciels de télésurveillance et des logiciels centrés sur le patient. Il propose également des valves aortiques, des produits de remplacement et de réparation des valves chirurgicales, des endoprothèses endovasculaires et des accessoires, des valves pulmonaires transcathéter, ainsi que des produits d'intervention coronaire percutanée, des ballons d'angioplastie percutanée et d'autres produits.

Medtronic plc Résumé des fondamentaux

Comment les bénéfices et les revenus de Medtronic se comparent-ils à sa capitalisation boursière ?
MDT statistiques fondamentales
Capitalisation boursièreUS$112.25b
Bénéfices(TTM)US$3.93b
Recettes(TTM)US$32.58b

28.6x

Ratio P/E

3.4x

Ratio P/S

Le site MDT est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
MDT compte de résultat (TTM)
RecettesUS$32.58b
Coût des recettesUS$11.23b
Marge bruteUS$21.35b
Autres dépensesUS$17.42b
Les revenusUS$3.93b

Derniers bénéfices déclarés

Jul 26, 2024

Prochaine date de publication des résultats

Nov 19, 2024

Résultat par action (EPS)3.06
Marge brute65.52%
Marge bénéficiaire nette12.05%
Ratio dettes/capitaux propres57.8%

Quelles ont été les performances à long terme de MDT?

Voir les performances historiques et les comparaisons

Dividendes

3.2%

Rendement actuel des dividendes

93%

Ratio de distribution